How long do revised and multiply revised knee replacements last? An analysis of the National Joint Registry.


Journal

The Lancet. Rheumatology
ISSN: 2665-9913
Titre abrégé: Lancet Rheumatol
Pays: England
ID NLM: 101765308

Informations de publication

Date de publication:
Jun 2021
Historique:
entrez: 19 1 2022
pubmed: 20 1 2022
medline: 20 1 2022
Statut: ppublish

Résumé

Knee replacements are common and effective operations but patients that undergo this intervention are at risk of needing subsequent costly and often complex revision surgery with poorer outcomes than primary surgery. The treatment pathway over the life of the patient in terms of risk of revision and re-revision(s) is poorly described. We aim to provide detailed information on the longevity of revision surgery. This was a retrospective observational registry-based study of the National Joint Registry. Kaplan-Meier estimates were used to determine the cumulative probability of revision and subsequent re-revision(s) following primary knee replacement. Analyses were stratified by age and gender and the influence of time from first to second revision on the risk of further revision was explored. There were 33,292 revision knee replacements with a linked primary episode. Revision rates of revision knee replacements were higher in males and younger patients. 19·9% of revisions were revised again within 13 years, 20·7% of second revisions were revised again within 5 years and 20·7% of third revisions were revised again within 3 years. A shorter time between revision episodes was associated with earlier subsequent revision. Males and younger patients are at higher risk of multiple revisions. Patients who undergo a revision have steadily increasing risk of further revision the more procedures they undergo, and each subsequent revision lasts for approximately half the time of the previous one. This study was supported by the NIHR Biomedical Research Centre at University Hospitals Bristol and Weston National Health Service Foundation Trust and the University of Bristol. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. This study was also supported by funding from Healthcare Quality Improvement Partnership and the National Joint Registry. Posts of authors of this work are part funded by a grant from the National Joint Registry to conduct statistical analysis for the National Joint Registry. AS was funded by a Medical Research Council Strategic Skills Fellowship MR/L01226X/1.

Sections du résumé

BACKGROUND BACKGROUND
Knee replacements are common and effective operations but patients that undergo this intervention are at risk of needing subsequent costly and often complex revision surgery with poorer outcomes than primary surgery. The treatment pathway over the life of the patient in terms of risk of revision and re-revision(s) is poorly described. We aim to provide detailed information on the longevity of revision surgery.
METHODS METHODS
This was a retrospective observational registry-based study of the National Joint Registry. Kaplan-Meier estimates were used to determine the cumulative probability of revision and subsequent re-revision(s) following primary knee replacement. Analyses were stratified by age and gender and the influence of time from first to second revision on the risk of further revision was explored.
FINDINGS RESULTS
There were 33,292 revision knee replacements with a linked primary episode. Revision rates of revision knee replacements were higher in males and younger patients. 19·9% of revisions were revised again within 13 years, 20·7% of second revisions were revised again within 5 years and 20·7% of third revisions were revised again within 3 years. A shorter time between revision episodes was associated with earlier subsequent revision.
INTERPRETATION CONCLUSIONS
Males and younger patients are at higher risk of multiple revisions. Patients who undergo a revision have steadily increasing risk of further revision the more procedures they undergo, and each subsequent revision lasts for approximately half the time of the previous one.
FUNDING BACKGROUND
This study was supported by the NIHR Biomedical Research Centre at University Hospitals Bristol and Weston National Health Service Foundation Trust and the University of Bristol. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. This study was also supported by funding from Healthcare Quality Improvement Partnership and the National Joint Registry. Posts of authors of this work are part funded by a grant from the National Joint Registry to conduct statistical analysis for the National Joint Registry. AS was funded by a Medical Research Council Strategic Skills Fellowship MR/L01226X/1.

Identifiants

pubmed: 35043097
doi: 10.1016/S2665-9913(21)00079-5
pmc: PMC7612217
mid: EMS140569
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e438-e446

Subventions

Organisme : Medical Research Council
ID : MR/L01226X/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

Declaration of interests SKK and JM declare no competing interests. KD, MRW, AS, AJP and MRW are members of the National Joint registry lot 2 contract team. AJP reports personal fees from Zimmer Biomet, outside the submitted work. AWB is the PI on a grant funded by Stryker investigating the outcome of a total knee replacement manufactured by Stryker. AWB is also an editor of an Orthopaedic general textbook for which he receives royalty payments. MRW is PI on two NIHR funded grants investigating the treatment of knee cartilage defects and injections in the treatment of osteoarthritis. MRW is also co-applicant on a grant funded by Stryker investigating the outcome of a total knee replacement manufactured by Stryker; Additionally, his Institution receives market rate payments for teaching on basic science and hip replacement that he delivers on courses organised by Heraeus and DePuy. MRW is also an editor of an Orthopaedic general textbook for which he receives royalty payments.

Références

BMJ. 2017 Mar 28;356:j1131
pubmed: 28351833
PLoS One. 2016 Feb 12;11(2):e0149306
pubmed: 26871909
Bone Joint J. 2019 Jul;101-B(7_Supple_C):104-107
pubmed: 31256651
J Shoulder Elbow Surg. 2020 Dec;29(12):2601-2609
pubmed: 33190759
J Arthroplasty. 2020 Oct;35(10):2938-2943
pubmed: 32561262
Cochrane Database Syst Rev. 2017 Apr 12;4:CD001431
pubmed: 28402085
Biomed Res Int. 2018 Sep 25;2018:8987104
pubmed: 30356391
Clin Orthop Relat Res. 2006 May;446:29-33
pubmed: 16672868
Bone Joint J. 2015 Jun;97-B(6):723-8
pubmed: 26033049
Lancet. 2017 Apr 8;389(10077):1424-1430
pubmed: 28209371
BMJ Open. 2020 Jan 21;10(1):e031645
pubmed: 31969360
J Bone Joint Surg Am. 2007 Oct;89 Suppl 3:144-51
pubmed: 17908880
BMJ Open. 2019 Apr 29;9(4):e026736
pubmed: 31036709
BMJ Open. 2019 Apr 29;9(4):e026685
pubmed: 31036708
Int J Med Inform. 2020 Oct;142:104217
pubmed: 32853974
Osteoarthritis Cartilage. 2017 Apr;25(4):455-461
pubmed: 27856293
Knee Surg Sports Traumatol Arthrosc. 2021 Oct;29(10):3287-3298
pubmed: 32671435
Knee Surg Sports Traumatol Arthrosc. 2012 Jun;20(6):1049-56
pubmed: 21800167
Lancet. 2019 Feb 16;393(10172):655-663
pubmed: 30782341
J Arthroplasty. 2019 Jul;34(7S):S266-S270
pubmed: 30824295
J Arthroplasty. 2007 Sep;22(6 Suppl 2):106-10
pubmed: 17823027
Knee Surg Sports Traumatol Arthrosc. 2021 Feb;29(2):579-585
pubmed: 32279110
Bone Joint J. 2015 Aug;97-B(8):1076-81
pubmed: 26224824
J Arthroplasty. 2021 Feb;36(2):471-477.e6
pubmed: 33011013
Osteoarthritis Cartilage. 2012 Jun;20(6):519-24
pubmed: 22395038
J Arthroplasty. 2013 Aug;28(7):1130-4
pubmed: 23219625
BMC Sports Sci Med Rehabil. 2020 Jan 10;12:5
pubmed: 31938549
J Arthroplasty. 2019 Dec;34(12):3018-3022
pubmed: 31351856
JAMA. 2012 Sep 26;308(12):1227-36
pubmed: 23011713

Auteurs

Kevin Deere (K)

Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, 1st Floor Learning & Research Building, Southmead Hospital, Bristol, BS10 5NB, UK.

Michael R Whitehouse (MR)

Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, 1st Floor Learning & Research Building, Southmead Hospital, Bristol, BS10 5NB, UK.
National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol.

Setor K Kunutsor (SK)

Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, 1st Floor Learning & Research Building, Southmead Hospital, Bristol, BS10 5NB, UK.
National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol.

Adrian Sayers (A)

Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, 1st Floor Learning & Research Building, Southmead Hospital, Bristol, BS10 5NB, UK.

Andrew J Price (AJ)

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, Windmill Road, Oxford, OX3 7LD, UK.

James Mason (J)

Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.

Ashley W Blom (AW)

Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, 1st Floor Learning & Research Building, Southmead Hospital, Bristol, BS10 5NB, UK.
National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol.

Classifications MeSH